Trials / Completed
CompletedNCT04050527
Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort
International, Multicentre, Observational, Prospective, Longitudinal Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort (AboLiSh)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 438 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the protocol is to assess the longitudinal attainment of person-centered and function related goals of patients who receive AbobotulinumtoxinA (aboBoNT-A) injections for adult lower limb spasticity over a period of 16 months.
Conditions
Timeline
- Start date
- 2019-12-19
- Primary completion
- 2022-07-29
- Completion
- 2022-07-29
- First posted
- 2019-08-08
- Last updated
- 2022-08-05
Locations
51 sites across 9 countries: United States, Australia, Brazil, Canada, France, Germany, Italy, Poland, Russia
Source: ClinicalTrials.gov record NCT04050527. Inclusion in this directory is not an endorsement.